
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical Association Between Pharmacogenomics and Adverse Drug Reactions
Zhi-Wei Zhou, Xiao-Wu Chen, Kevin Sneed, et al.
Drugs (2015) Vol. 75, Iss. 6, pp. 589-631
Closed Access | Times Cited: 64
Zhi-Wei Zhou, Xiao-Wu Chen, Kevin Sneed, et al.
Drugs (2015) Vol. 75, Iss. 6, pp. 589-631
Closed Access | Times Cited: 64
Showing 26-50 of 64 citing articles:
CYP2D7 Sequence Variation Interferes with TaqMan CYP2D6*15 and *35 Genotyping
Amanda K. Riffel, Mehdi Dehghani, Toinette Hartshorne, et al.
Frontiers in Pharmacology (2016) Vol. 6
Open Access | Times Cited: 16
Amanda K. Riffel, Mehdi Dehghani, Toinette Hartshorne, et al.
Frontiers in Pharmacology (2016) Vol. 6
Open Access | Times Cited: 16
Genetic associations of docetaxel‐based chemotherapy‐induced myelosuppression in Chinese Han population
Weihua Ren, Chenxi Zhou, Yedong Liu, et al.
Journal of Clinical Pharmacy and Therapeutics (2019) Vol. 45, Iss. 2, pp. 354-364
Open Access | Times Cited: 13
Weihua Ren, Chenxi Zhou, Yedong Liu, et al.
Journal of Clinical Pharmacy and Therapeutics (2019) Vol. 45, Iss. 2, pp. 354-364
Open Access | Times Cited: 13
Calculation of the pharmacogenomics benefit score for patients with medication-related problems
Thomas M. Polasek
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 4
Thomas M. Polasek
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 4
The relationship between sensory processing sensitivity and medication sensitivity: brief report
Jadzia Jagiellowicz, Bianca P. Acevedo, Teresa Tillmann, et al.
Frontiers in Psychology (2024) Vol. 14
Open Access | Times Cited: 1
Jadzia Jagiellowicz, Bianca P. Acevedo, Teresa Tillmann, et al.
Frontiers in Psychology (2024) Vol. 14
Open Access | Times Cited: 1
Pharmacogenomics-Guided Pharmacotherapy in Patients with Major Depressive Disorder or Bipolar Disorder Affected by Treatment-Resistant Depressive Episodes: A Long-Term Follow-Up Study
Antonio Del Casale, Leda Marina Pomes, Luca Bonanni, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 2, pp. 316-316
Open Access | Times Cited: 7
Antonio Del Casale, Leda Marina Pomes, Luca Bonanni, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 2, pp. 316-316
Open Access | Times Cited: 7
Metabolic Drug Interactions with Immunosuppressants
Katalin Monostory
InTech eBooks (2018)
Open Access | Times Cited: 10
Katalin Monostory
InTech eBooks (2018)
Open Access | Times Cited: 10
Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer’s Disease
Ramón Cacabelos, Juan C. Carril, Lola Corzo, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 4, pp. 366-366
Open Access | Times Cited: 8
Ramón Cacabelos, Juan C. Carril, Lola Corzo, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 4, pp. 366-366
Open Access | Times Cited: 8
Genetic analysis of pharmacogenomic VIP variants in the Wa population from Yunnan Province of China
Dandan Li, Linna Peng, Shishi Xing, et al.
BMC Genomic Data (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Dandan Li, Linna Peng, Shishi Xing, et al.
BMC Genomic Data (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 7
EPIDEMIOLOGICAL INTERSECTION: THE REVELATION OF COVID – 19 PANDEMIC
R. Vinodh Rajkumar
International Journal of Physiotherapy and Research (2020) Vol. 8, Iss. 2, pp. 3438-3442
Closed Access | Times Cited: 6
R. Vinodh Rajkumar
International Journal of Physiotherapy and Research (2020) Vol. 8, Iss. 2, pp. 3438-3442
Closed Access | Times Cited: 6
Utilization of Drug Decision Support Strategies Including Drug Characteristics to Reduce the Risk of Iatrogenesis in Advanced Age
Savanna San Filippo, Marshall Yuan, Edward Y. L. Gu, et al.
Current Pharmacology Reports (2023) Vol. 9, Iss. 1, pp. 32-42
Closed Access | Times Cited: 2
Savanna San Filippo, Marshall Yuan, Edward Y. L. Gu, et al.
Current Pharmacology Reports (2023) Vol. 9, Iss. 1, pp. 32-42
Closed Access | Times Cited: 2
Patient Attitudes Toward Pharmacogenetic Testing in Psychiatric Treatment
Jonathan Tamaiev, Zachary Bergson, Xiaowei Sun, et al.
Current Behavioral Neuroscience Reports (2023) Vol. 10, Iss. 2, pp. 30-40
Closed Access | Times Cited: 2
Jonathan Tamaiev, Zachary Bergson, Xiaowei Sun, et al.
Current Behavioral Neuroscience Reports (2023) Vol. 10, Iss. 2, pp. 30-40
Closed Access | Times Cited: 2
Post-Marketing Drug Withdrawals: A Review
Nutan Rao, Roshani Powar
Pharmaceutical Chemistry Journal (2023) Vol. 57, Iss. 7, pp. 1138-1146
Closed Access | Times Cited: 2
Nutan Rao, Roshani Powar
Pharmaceutical Chemistry Journal (2023) Vol. 57, Iss. 7, pp. 1138-1146
Closed Access | Times Cited: 2
Pharmacogenomic Profile of Amazonian Amerindians
Juliana Carla Gomes Rodrigues, Marianne Rodrigues Fernandes, André M. Ribeiro-dos-Santos, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 952-952
Open Access | Times Cited: 4
Juliana Carla Gomes Rodrigues, Marianne Rodrigues Fernandes, André M. Ribeiro-dos-Santos, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 6, pp. 952-952
Open Access | Times Cited: 4
Perspectives of the use of pharmacogenetic tests in neurology and psychiatry
G. P. Kostyuk, Natalia V. Zakharova, A M Reznik, et al.
S S Korsakov Journal of Neurology and Psychiatry (2019) Vol. 119, Iss. 9, pp. 131-131
Closed Access | Times Cited: 4
G. P. Kostyuk, Natalia V. Zakharova, A M Reznik, et al.
S S Korsakov Journal of Neurology and Psychiatry (2019) Vol. 119, Iss. 9, pp. 131-131
Closed Access | Times Cited: 4
Sub-Analysis of CYP-GUIDES Data: Assessing the Prevalence and Impact of Drug-Gene Interactions in an Ethnically Diverse Cohort of Depressed Individuals
Rustin D. Crutchley, Nicole Keuler
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Rustin D. Crutchley, Nicole Keuler
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Targeted next-generation sequencing panel to investigate antiplatelet adverse reactions in acute coronary syndrome patients undergoing percutaneous coronary intervention with stenting
Alba Antúnez-Rodríguez, S. García-Rodríguez, Ana Pozo-Agundo, et al.
Thrombosis Research (2024) Vol. 240, pp. 109060-109060
Closed Access
Alba Antúnez-Rodríguez, S. García-Rodríguez, Ana Pozo-Agundo, et al.
Thrombosis Research (2024) Vol. 240, pp. 109060-109060
Closed Access
MTHFR 677 C>T- and 1298 A>C-related adverse effects in 5-fluorouracil-based chemotherapy in the Asian population: a systematic review and meta-analysis
Yu Bai, Dan Jiang, Yong-qing Wen, et al.
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Yu Bai, Dan Jiang, Yong-qing Wen, et al.
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Genomic analysis of human polymorphisms affecting drug-protein interactions
Oriol Pich, Anna Vlasova, Polina Shichkova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2017)
Open Access | Times Cited: 3
Oriol Pich, Anna Vlasova, Polina Shichkova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2017)
Open Access | Times Cited: 3
Precision Medicine and Challenges in Research and Clinical Implementation
Susanne B. Haga
Elsevier eBooks (2017), pp. 717-732
Closed Access | Times Cited: 3
Susanne B. Haga
Elsevier eBooks (2017), pp. 717-732
Closed Access | Times Cited: 3
Editorial: Improving cancer chemotherapy through pharmacogenomics: a research topic
Luis A. Quiñones, Kuen S. Lee
Frontiers in Genetics (2015) Vol. 6
Open Access | Times Cited: 2
Luis A. Quiñones, Kuen S. Lee
Frontiers in Genetics (2015) Vol. 6
Open Access | Times Cited: 2
Pharmacogenomics Influencing Drug-Gene Interactions Leading Towards Personalized Medicine
Kaiser Jamil
Journal of Pharmacogenomics & Pharmacoproteomics (2015) Vol. 06, Iss. 03
Open Access | Times Cited: 2
Kaiser Jamil
Journal of Pharmacogenomics & Pharmacoproteomics (2015) Vol. 06, Iss. 03
Open Access | Times Cited: 2
Social and Ethical Implications of Integrating Precision Medicine into Healthcare
Evangel Sarwar
Advancing global bioethics (2023), pp. 125-156
Closed Access | Times Cited: 1
Evangel Sarwar
Advancing global bioethics (2023), pp. 125-156
Closed Access | Times Cited: 1
CORR Insights®: Does Preoperative Pharmacogenomic Testing of Patients Undergoing TKA Improve Postoperative Pain? A Randomized Trial
F. Kayser Enneking
Clinical Orthopaedics and Related Research (2023)
Closed Access | Times Cited: 1
F. Kayser Enneking
Clinical Orthopaedics and Related Research (2023)
Closed Access | Times Cited: 1
Transfer learning enhanced graph neural network for aldehyde oxidase metabolism prediction and its experimental application
Jiacheng Xiong, Rongrong Cui, Zhaojun Li, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 2, pp. 623-634
Open Access | Times Cited: 1
Jiacheng Xiong, Rongrong Cui, Zhaojun Li, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 2, pp. 623-634
Open Access | Times Cited: 1
Structure–activity relationships and interindividual variability of drug responses: pharmacogenomics with antimicrobial drugs as a paradigm
Romany H. Thabet, Bayan Osama Shehadeh Alshar, Doaa Habes Saleh Alabdallah, et al.
Journal of International Medical Research (2023) Vol. 51, Iss. 11
Open Access | Times Cited: 1
Romany H. Thabet, Bayan Osama Shehadeh Alshar, Doaa Habes Saleh Alabdallah, et al.
Journal of International Medical Research (2023) Vol. 51, Iss. 11
Open Access | Times Cited: 1